Fentanyl: what to check before you give it

Why this drug and not another

Fentanyl's potency and short onset by the IV route make it the choice for severe acute pain, procedural sedation and anesthesia induction, where morphine acts too slowly or requires volumes that complicate rapid titration. Its lipophilicity lets it cross the blood-brain barrier fast, which is exactly why the same property makes the transdermal patch behave so differently from a pill.

In the transdermal form, that lipophilicity means the drug forms a depot in subcutaneous fat before reaching circulation. That depot is the reason fentanyl patches are prescribed for chronic, stable pain in opioid-tolerant patients rather than acute or fluctuating pain — the delivery system cannot be titrated quickly enough for a patient whose pain changes hour to hour.

Administration and timing

The patch takes 12 to 24 hours to reach therapeutic effect after application, and analgesia from a prior dose continues for a similar window after the patch is removed. A patient switching from oral opioids needs overlapping coverage during that first day, and a patient who has just removed a patch is not opioid-free the moment it comes off — respiratory depression risk persists for many hours afterward.

Heat applied to or near the patch increases blood flow to the skin and can release the drug faster than the depot was designed to, effectively dumping hours of dose at once. Teach patients explicitly: no heating pads, no electric blankets, no hot tubs or saunas over the patch site, and flag fever as a reason to reassess dosing, since a febrile patient absorbs more drug through warmed skin.

IV fentanyl, by contrast, acts within minutes and wears off quickly, which is why it suits short procedures but requires continuous monitoring during administration rather than the intermittent checks a patch allows.

Monitoring parameters

Respiratory rate is the parameter that matters most. Check it before every IV dose and hold if below 12/min pending provider contact, and continue monitoring rate and depth for the duration of patch use, not just after application. Sedation level predicts respiratory depression earlier than the respiratory rate itself, so a validated sedation scale should be checked alongside it.

For the patch, monitor the application site for erythema or signs the adhesive has failed, and confirm the patch is intact at each shift. Track pain scores against the 12 to 24 hour onset window rather than expecting immediate relief, and monitor bowel function throughout, since opioid-induced constipation does not resolve on its own and a bowel regimen should start with the first dose.

Adverse effects to report

Respiratory depression is the emergency to escalate immediately, alongside oxygen saturation below the patient's baseline and increasing sedation. Naloxone should be available at the bedside for any patient on fentanyl, and staff should know the dose is often repeated because fentanyl's effect can outlast a single naloxone dose.

Also report hypotension, especially with IV administration, and any sign of serotonin excess if fentanyl is combined with another serotonergic drug, since fentanyl carries some serotonergic activity itself. Chest wall rigidity is a rare but serious effect specific to rapid IV fentanyl administration and warrants immediate provider notification if breathing becomes difficult during or right after a dose.

Contraindications and cautions

Fentanyl patches are contraindicated in opioid-naive patients and in acute or postoperative pain because the slow, unadjustable release cannot match a rapidly changing pain picture and risks fatal respiratory depression in someone without opioid tolerance. Use caution in patients with hepatic or renal impairment, since metabolism and clearance slow and effects accumulate.

Avoid combining fentanyl with other CNS depressants, including benzodiazepines and alcohol, without close monitoring, and use caution with any drug that raises serotonin given fentanyl's own serotonergic activity. Cachectic or very thin patients absorb transdermal fentanyl less predictably because the subcutaneous depot depends on adequate fat tissue.

Teaching points the exam tests

Expect exam items built around the heat rule: a patient asking about a heating pad for back pain while wearing a fentanyl patch is a classic distractor testing whether you catch the interaction. The correct response is to redirect away from any heat source over or near the patch, not simply to lower the room temperature.

Also expect timing questions — a patient who had a patch removed two hours ago is not cleared for another opioid at full dose, because the prior patch continues releasing drug for hours after removal. And expect disposal questions: used patches still contain active drug and must be folded adhesive-to-adhesive and disposed of according to facility policy, since discarded patches are a known source of accidental pediatric exposure and diversion.